A trial to assess nalmefene in combination with an atypical antipsychotic in patients with alcohol dependence and comorbid, chronic schizophrenia.
Phase of Trial: Phase IV
Latest Information Update: 25 Nov 2014
At a glance
- Drugs Nalmefene (Primary)
- Indications Alcoholism
- Focus Adverse reactions; Therapeutic Use
- 25 Nov 2014 New trial record
- 20 Oct 2014 Results presented at the 27th Annual Congress of the European College of Neuropsychopharmacology.